GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000041 | Transition metal ion transport |
| Process | GO:0002526 | Acute inflammatory response |
| Process | GO:0002791 | Regulation of peptide secretion |
| Process | GO:0002793 | Positive regulation of peptide secretion |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006810 | Transport |
| Process | GO:0006811 | Ion transport |
| Process | GO:0006812 | Cation transport |
| Process | GO:0006826 | Iron ion transport |
| Process | GO:0006873 | Cellular ion homeostasis |
| Process | GO:0006875 | Cellular metal ion homeostasis |
| Process | GO:0006879 | Cellular iron ion homeostasis |
| Process | GO:0006897 | Endocytosis |
| Process | GO:0006898 | Receptor-mediated endocytosis |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006953 | Acute-phase response |
| Process | GO:0006954 | Inflammatory response |
| Process | GO:0008104 | Protein localization |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010038 | Response to metal ion |
| Process | GO:0010039 | Response to iron ion |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010817 | Regulation of hormone levels |
| Process | GO:0015031 | Protein transport |
| Process | GO:0016192 | Vesicle-mediated transport |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019725 | Cellular homeostasis |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0030001 | Metal ion transport |
| Process | GO:0030003 | Cellular cation homeostasis |
| Process | GO:0030100 | Regulation of endocytosis |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033212 | Iron import into cell |
| Process | GO:0033572 | Transferrin transport |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0045184 | Establishment of protein localization |
| Process | GO:0045807 | Positive regulation of endocytosis |
| Process | GO:0045893 | Positive regulation of transcription, DNA-templated |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045944 | Positive regulation of transcription by RNA polymerase II |
| Process | GO:0046883 | Regulation of hormone secretion |
| Process | GO:0046887 | Positive regulation of hormone secretion |
| Process | GO:0046916 | Cellular transition metal ion homeostasis |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048878 | Chemical homeostasis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050801 | Ion homeostasis |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051046 | Regulation of secretion |
| Process | GO:0051047 | Positive regulation of secretion |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051050 | Positive regulation of transport |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051130 | Positive regulation of cellular component organization |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051247 | Positive regulation of protein metabolic process |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051254 | Positive regulation of RNA metabolic process |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051649 | Establishment of localization in cell |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0055065 | Metal ion homeostasis |
| Process | GO:0055072 | Iron ion homeostasis |
| Process | GO:0055076 | Transition metal ion homeostasis |
| Process | GO:0055080 | Cation homeostasis |
| Process | GO:0055082 | Cellular chemical homeostasis |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0070727 | Cellular macromolecule localization |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071241 | Cellular response to inorganic substance |
| Process | GO:0071248 | Cellular response to metal ion |
| Process | GO:0071281 | Cellular response to iron ion |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0090087 | Regulation of peptide transport |
| Process | GO:0090276 | Regulation of peptide hormone secretion |
| Process | GO:0090277 | Positive regulation of peptide hormone secretion |
| Process | GO:0098657 | Import into cell |
| Process | GO:0098771 | Inorganic ion homeostasis |
| Process | GO:0140298 | Endocytic iron import into cell |
| Process | GO:1902680 | Positive regulation of RNA biosynthetic process |
| Process | GO:1903317 | Regulation of protein maturation |
| Process | GO:1903319 | Positive regulation of protein maturation |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903508 | Positive regulation of nucleic acid-templated transcription |
| Process | GO:1903530 | Regulation of secretion by cell |
| Process | GO:1903532 | Positive regulation of secretion by cell |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005887 | Integral component of plasma membrane |
| Component | GO:0009897 | External side of plasma membrane |
| Component | GO:0009986 | Cell surface |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031226 | Intrinsic component of plasma membrane |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031982 | Vesicle |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043235 | Receptor complex |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0098552 | Side of membrane |
| Component | GO:0098796 | Membrane protein complex |
| Component | GO:0098797 | Plasma membrane protein complex |
| Component | GO:0098802 | Plasma membrane signaling receptor complex |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:1990712 | HFE-transferrin receptor complex |
| Function | GO:0004998 | Transferrin receptor activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0038024 | Cargo receptor activity |
| Function | GO:0039706 | Co-receptor binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | MMU-382551 | Transport of small molecules |
| RCTM | MMU-917937 | Iron uptake and transport |
| RCTM | MMU-917977 | Transferrin endocytosis and recycling |
| WikiPathways | WP1596 | Iron homeostasis |
| KEGG | mmu04350 | TGF-beta signaling pathway |
Expression profile of Tfr2 in omics data
| ID | GSE106799 |
| Title | Propofol alters the mRNA profile in the developing mouse hippocampus |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2850452 | Control 1 | tissue: hippocampus age: 7 days-old | 7.8089266 |
| GSM2850453 | Control 2 | tissue: hippocampus age: 7 days-old | 7.7214136 |
| GSM2850454 | Control 3 | tissue: hippocampus age: 7 days-old | 8.131157 |
| GSM2850455 | Control 4 | tissue: hippocampus age: 7 days-old | 7.8500624 |
| GSM2850456 | Propofol 1 | tissue: hippocampus age: 7 days-old | 8.062525 |
| GSM2850457 | Propofol 2 | tissue: hippocampus age: 7 days-old | 7.517901 |
| GSM2850458 | Propofol 3 | tissue: hippocampus age: 7 days-old | 7.7700014 |
| GSM2850459 | Propofol 4 | tissue: hippocampus age: 7 days-old | 8.103728 |
| ID | GSE109165 |
| Title | Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2934457 | WT_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 201.0 |
| GSM2934458 | WT_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 478.0 |
| GSM2934459 | WT_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 461.0 |
| GSM2934460 | WT_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 364.0 |
| GSM2934461 | KO_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 502.0 |
| GSM2934462 | KO_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 307.0 |
| GSM2934463 | KO_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 235.0 |
| GSM2934464 | KO_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 319.0 |
| GSM2934465 | WT_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 225.0 |
| GSM2934466 | WT_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 228.0 |
| GSM2934467 | WT_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 400.0 |
| GSM2934468 | WT_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 316.0 |
| GSM2934469 | KO_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 282.0 |
| GSM2934470 | KO_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 129.0 |
| GSM2934471 | KO_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 133.0 |
| GSM2934472 | KO_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 285.0 |
| ID | GSE125076 |
| Title | A mouse model of acute post-surgical pain |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3562188 | DRG_WT_sham_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 65.0 |
| GSM3562189 | DRG_WT_sham_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 41.0 |
| GSM3562190 | DRG_WT_sham_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 69.0 |
| GSM3562191 | DRG_WT_PSP_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 102.0 |
| GSM3562192 | DRG_WT_PSP_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 66.0 |
| GSM3562193 | DRG_WT_PSP_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 88.0 |
| ID | GSE126662 |
| Title | Comparison between opioid (morphine) and vehicle treatments in mouse trigeminal ganglia and nucleus accumbens |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3610703 | TG_M1: OIH_M1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 21.819675 |
| GSM3610704 | TG_M2: OIH_M2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 20.9906875 |
| GSM3610705 | TG_M3: OIH_M3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 27.0369 |
| GSM3610706 | TG_M4: OIH_M4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 25.90225 |
| GSM3610707 | TG_M5: OIH_M5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 33.046099999999996 |
| GSM3610708 | TG_V1: VehicleOIH_V1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 27.18775 |
| GSM3610709 | TG_V2: VehicleOIH_V2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 39.502425 |
| GSM3610710 | TG_V3: VehicleOIH_V3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 26.58841855 |
| GSM3610711 | TG_V4: VehicleOIH_V4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 23.67495 |
| GSM3610712 | TG_V5: VehicleOIH_V5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 34.81855 |
| GSM3610713 | NAc_M1: OIH_M1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 44.703250000000004 |
| GSM3610714 | NAc_M2: OIH_M2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 38.69505 |
| GSM3610715 | NAc_M3: OIH_M3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 33.757400000000004 |
| GSM3610716 | NAc_M4: OIH_M4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 36.9324 |
| GSM3610717 | NAc_M5: OIH_M5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 45.0202 |
| GSM3610718 | NAc_V1: VehicleOIH_V1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 44.58605 |
| GSM3610719 | NAc_V2: VehicleOIH_V2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 46.505925000000005 |
| GSM3610720 | NAc_V3: VehicleOIH_V3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 31.04775 |
| GSM3610721 | NAc_V4: VehicleOIH_V4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 43.649965 |
| GSM3610722 | NAc_V5: VehicleOIH_V5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 26.9209 |
| ID | GSE138802 |
| Title | Mesocorticolimbic circuit mechanisms underlying the effects of ketamine on dopamine: a translational imaging study |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4119733 | PLc_1_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 173.38 |
| GSM4119734 | PLc_10_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 184.49 |
| GSM4119735 | PLc_6_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 200.74 |
| GSM4119736 | PLc_5_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 163.69 |
| GSM4119737 | PLc_3_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 131.17 |
| GSM4119738 | PLc_9_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 123.28 |
| ID | GSE163828 |
| Title | Regulation of electro-acupuncture(EA) and astragalus membranaceus (AM) on genes in bone marrow |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4988039 | BH190126-1_control | tissue: bone marrow | 5.93 |
| GSM4988040 | BH190126-1_treatment of astragalus membranaceus | tissue: bone marrow | 6.2 |
| GSM4988041 | BH190126-1_cisplatin | tissue: bone marrow | 6.08 |
| GSM4988042 | BH190126-1_treatment of electro-acupuncture | tissue: bone marrow | 6.18 |
| ID | GSE20160 |
| Title | Gene Expression Data from Prefrontal Cortex and Nucleus Accumbens from Inbred Strains of Mice |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM505749 | 129S1/SvImJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: 129S1/SvImJ | 24.386499999999998 |
| GSM505750 | A/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: A/J | 14.051 |
| GSM505751 | AKR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: AKR/J | 16.258499999999998 |
| GSM505752 | BALB/cByJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BALB/cByJ | 15.439 |
| GSM505753 | BTBR_T+_tf/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BTBR_T+_tf/J | 18.0355 |
| GSM505754 | BUB/BnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BUB/BnJ | 19.4365 |
| GSM505755 | C3H/HeJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C3H/HeJ | 19.5665 |
| GSM505756 | C57BL/6J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BL/6J | 13.852 |
| GSM505757 | C57BR/cdJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BR/cdJ | 17.7925 |
| GSM505758 | C58/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C58/J | 19.511 |
| GSM505759 | CBA/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CBA/J | 17.947499999999998 |
| GSM505760 | CE/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CE/J | 17.3385 |
| GSM505761 | DBA/2J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: DBA/2J | 17.553 |
| GSM505762 | FVB/NJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: FVB/NJ | 17.4095 |
| GSM505763 | I/LnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: I/LnJ | 13.315000000000001 |
| GSM505764 | KK/HlJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: KK/HlJ | 20.6485 |
| GSM505765 | MA/MyJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MA/MyJ | 13.926000000000002 |
| GSM505766 | MRL_MpJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MRL/MpJ | 15.803999999999998 |
| GSM505767 | NOD/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NOD/LtJ | 16.561 |
| GSM505768 | NON/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NON/LtJ | 19.4095 |
| GSM505769 | NZO/HILtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZO/HILtJ | 17.0485 |
| GSM505770 | NZW_LacJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZW_LacJ | 16.722 |
| GSM505771 | P/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: P/J | 22.5765 |
| GSM505772 | PL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: PL/J | 17.491500000000002 |
| GSM505773 | RIIIS/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: RIIIS/J | 18.696 |
| GSM505774 | SJL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SJL/J | 11.846499999999999 |
| GSM505775 | SM/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SM/J | 15.258499999999998 |
| GSM505776 | SWR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SWR/J | 25.3915 |
| GSM505777 | WSB/EiJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: WSB/EiJ | 23.6415 |
| GSM505778 | 129S1/SvImJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: 129S1/SvImJ | 9.17 |
| GSM505779 | A/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: A/J | 8.014 |
| GSM505780 | AKR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: AKR/J | 11.376 |
| GSM505781 | BALB/cByJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BALB/cByJ | 10.6065 |
| GSM505782 | BTBR_T+_tf/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BTBR_T+_tf/J | 11.78 |
| GSM505783 | BUB/BnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BUB/BnJ | 8.599 |
| GSM505784 | C3H/HeJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C3H/HeJ | 8.579 |
| GSM505785 | C57BL/6J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BL/6J | 8.6765 |
| GSM505786 | C57BR/cdJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BR/cdJ | 8.688 |
| GSM505787 | C58/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C58/J | 9.753 |
| GSM505788 | CBA/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CBA/J | 9.586 |
| GSM505789 | CE/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CE/J | 10.113 |
| GSM505790 | DBA/2J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: DBA/2J | 10.582 |
| GSM505791 | FVB/NJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: FVB/NJ | 7.925 |
| GSM505792 | I/LnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: I/LnJ | 7.718 |
| GSM505793 | KK/HlJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: KK/HlJ | 10.084 |
| GSM505794 | MA/MyJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: MA/MyJ | 6.6845 |
| GSM505795 | NOD/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NOD/LtJ | 8.664 |
| GSM505796 | NON/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NON/LtJ | 9.6615 |
| GSM505797 | NZW/LacJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NZW/LacJ | 8.5335 |
| GSM505798 | P/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: P/J | 8.9405 |
| GSM505799 | PL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: PL/J | 8.6295 |
| GSM505800 | RIIIS/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: RIIIS/J | 8.369 |
| GSM505801 | SJL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SJL/J | 8.184000000000001 |
| GSM505802 | SM/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SM/J | 8.1105 |
| GSM505803 | SWR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SWR/J | 8.820500000000001 |
| GSM505804 | WSB/EiJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: WSB/EiJ | 8.433 |
| ID | GSE205201 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [mouse] |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208462 | Mouse_Baseline_0h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 12.72553 |
| GSM6208463 | Mouse_Baseline_0h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 12.99303 |
| GSM6208464 | Mouse_Baseline_0h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 12.86435 |
| GSM6208465 | Mouse_Baseline_0h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 12.84483 |
| GSM6208466 | Mouse_Baseline_0h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 12.8714 |
| GSM6208467 | Mouse_Vehicle_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 12.78866 |
| GSM6208468 | Mouse_Vehicle_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 12.80528 |
| GSM6208469 | Mouse_Vehicle_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 12.71956 |
| GSM6208470 | Mouse_Vehicle_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 12.7101 |
| GSM6208471 | Mouse_Vehicle_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 12.65579 |
| GSM6208472 | Mouse_Vehicle_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 12.72117 |
| GSM6208473 | Mouse_Vehicle_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 12.60223 |
| GSM6208474 | Mouse_Vehicle_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 12.78475 |
| GSM6208475 | Mouse_Vehicle_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 12.71251 |
| GSM6208476 | Mouse_Vehicle_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 12.72855 |
| GSM6208477 | Mouse_Vehicle_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 12.56992 |
| GSM6208478 | Mouse_Vehicle_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 12.69893 |
| GSM6208479 | Mouse_Vehicle_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 12.63223 |
| GSM6208480 | Mouse_Vehicle_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 12.5623 |
| GSM6208481 | Mouse_Vehicle_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 12.46718 |
| GSM6208482 | Mouse_Vehicle_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 12.62444 |
| GSM6208483 | Mouse_Vehicle_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 12.74557 |
| GSM6208484 | Mouse_Vehicle_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 12.72092 |
| GSM6208485 | Mouse_Vehicle_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 12.61648 |
| GSM6208486 | Mouse_Vehicle_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 12.71116 |
| GSM6208487 | Mouse_APAP_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 12.74983 |
| GSM6208488 | Mouse_APAP_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 12.64543 |
| GSM6208489 | Mouse_APAP_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 12.70207 |
| GSM6208490 | Mouse_APAP_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 12.69171 |
| GSM6208491 | Mouse_APAP_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 12.85975 |
| GSM6208492 | Mouse_APAP_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 12.71312 |
| GSM6208493 | Mouse_APAP_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 12.65083 |
| GSM6208494 | Mouse_APAP_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 12.68617 |
| GSM6208495 | Mouse_APAP_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 12.69789 |
| GSM6208496 | Mouse_APAP_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 12.69683 |
| GSM6208497 | Mouse_APAP_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 12.6072 |
| GSM6208498 | Mouse_APAP_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 12.62304 |
| GSM6208499 | Mouse_APAP_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 12.60327 |
| GSM6208500 | Mouse_APAP_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 12.5585 |
| GSM6208501 | Mouse_APAP_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 12.68883 |
| GSM6208502 | Mouse_APAP_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 12.68096 |
| GSM6208503 | Mouse_APAP_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 12.81311 |
| GSM6208504 | Mouse_APAP_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 12.79384 |
| GSM6208505 | Mouse_APAP_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 12.73721 |
| GSM6208506 | Mouse_APAP_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 12.66685 |
| ID | GSE223541 |
| Title | Oxycodone withdrawal induces HDAC1/2-dependent transcriptional maladaptations in the reward pathway in a murine model of peripheral nerve injury |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6958536 | B1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sa | 24.0 |
| GSM6958537 | C1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 39.0 |
| GSM6958538 | F1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 7.0 |
| GSM6958539 | H1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 15.0 |
| GSM6958540 | B2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 55.0 |
| GSM6958541 | C2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 11.0 |
| GSM6958542 | F2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 24.0 |
| GSM6958543 | H2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 9.0 |
| GSM6958544 | B3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 41.0 |
| GSM6958545 | C3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 23.0 |
| GSM6958546 | F3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 2.0 |
| GSM6958547 | H3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 18.0 |
| GSM6958548 | B4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 18.0 |
| GSM6958549 | C4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 11.0 |
| GSM6958550 | F4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 9.0 |
| GSM6958551 | H4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 33.0 |
| ID | GSE24829 |
| Title | Gene expression data from striatal regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 5.86383 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 5.61153 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 5.80027 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 5.65791 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 5.76251 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 5.70877 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 5.76479 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 5.77774 |
| ID | GSE24830 |
| Title | Gene expression data from cervical spinal cord regions of MPTP-intoxicated mouse by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 4.99926 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 4.92155 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 5.02099 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 4.77115 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.64254 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.81702 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.53662 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.76051 |
| ID | GSE24838 |
| Title | Gene expression data from brain striatal and spinal cord regions of MPTP-intoxicated mouse following acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 5.86383 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 5.61153 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 5.80027 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 5.65791 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 5.76251 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 5.70877 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 5.76479 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 5.77774 |
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 4.99926 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 4.92155 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 5.02099 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 4.77115 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.64254 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.81702 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.53662 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.76051 |
| ID | GSE26364 |
| Title | Gene expression changes in alpha GABA receptors in the mice brains after prolonged ketamine administration |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM647254 | Saline PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 4.29927 |
| GSM647255 | Saline PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 4.50881 |
| GSM647256 | Ketamine PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 4.57422 |
| GSM647257 | Ketamine PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 4.47283 |
| ID | GSE35138 |
| Title | Gene expression data from thalamic regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM862520 | Control mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.65095 |
| GSM862521 | Control mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.79237 |
| GSM862522 | MPTP-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.58374 |
| GSM862523 | MPTP-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.86249 |
| GSM862524 | MPTP and acupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.86521 |
| GSM862525 | MPTP and acupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.65099 |
| GSM862526 | MPTP and nonacupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.56028 |
| GSM862527 | MPTP and nonacupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 5.53618 |
| ID | GSE48293 |
| Title | Gene expression data from substantia nigral regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1174263 | Control mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 3.50415 |
| GSM1174264 | Control mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 4.53812 |
| GSM1174265 | MPTP-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 4.9228 |
| GSM1174266 | MPTP-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 4.70431 |
| GSM1174267 | MPTP and acupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.69804 |
| GSM1174268 | MPTP and acupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 4.75015 |
| GSM1174269 | MPTP and nonacupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.43744 |
| GSM1174270 | MPTP and nonacupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 4.30577 |
